TCL Archive Phase III Trial Fails to Extend OS After Meeting Primary Endpoint Of Durable Response Rate April 25, 2014
TCL Archive Unorthodox Panel Considers NIH Mandated Role In Study of Unconventional Medical Practices June 26, 1992
TCL Archive Six-Year Follow Up Of Phase III Sprycel Trial Demonstrates 71 Percent Overall Survival July 27, 2012
TCL Archive In Brief: Biomedical Panel Report Will Support Cancer Program, Targeted Research January 16, 1976
